Comparative in vitro activity of oral antimicrobial agents against Enterobacteriaceae from patients with community-acquired urinary tract infections in three European countries

Kresken, M.Koerber-Irrgang, B.Biedenbach, D. J.Batista, N.Besard, V.Canton, R.Garcia-Castillo, M.Kalka-Moll, W.Pascual, A.Schwarz, R.Van Meensel, B.Wisplinghoff, H.Seifert, H.2023-02-122023-02-122016-01-011198-743Xhttp://hdl.handle.net/10668/18745Enterobacteriaceae causing community-acquired urinary tract infections were examined in selected outpatient clinics and hospitals in Belgium, Germany and Spain using EUCAST breakpoints for susceptibility. A total of 1190 isolates were collected. Escherichia coli isolates were resistant to amoxicillin-clavulanic acid (28.1%), ciprofloxacin (23.4%) and trimethoprim-sulfamethoxazole (21.4%) compared with fosfomycin and nitrofurantoin (each,enAgecephalosporinextended-spectrum beta-lactamase ratesgenderresistanceEscherichia-coliBeta-lactamasesResistanceSusceptibilityTrimethoprimAntibioticsPathogensEvolutionTherapyComparative in vitro activity of oral antimicrobial agents against Enterobacteriaceae from patients with community-acquired urinary tract infections in three European countriesresearch articleopen access10.1016/j.cmi.2015.08.0191469-0691http://www.clinicalmicrobiologyandinfection.com/article/S1198743X15008058/pdf368024800017